Wordt geladen...
Use of broadly neutralizing antibodies for HIV-1 prevention
Antibodies have a long history in antiviral therapy, but until recently they have not been actively pursued for HIV-1 due to modest potency and breadth of early human monoclonal antibodies (MAbs) and perceived insurmountable technical, financial, and logistical hurdles. Recent advances in the identi...
Bewaard in:
| Gepubliceerd in: | Immunol Rev |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5314445/ https://ncbi.nlm.nih.gov/pubmed/28133803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12511 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|